Intragenic ERBB2 kinase mutations in tumours

作者：Philip Stephens, Chris Hunter, Graham R. Bignell, Sarah Edkins, Helen Ruth Davies, Jon W. Teague, Claire Stevens, Sarah O’Meara, Raffaella Smith, Adrian G. Parker, Andy Barthorpe, Matthew James Blow, Lisa Brackenbury, Adam P. Butler, Oliver B. Clarke, Jennifer M. Cole, Ed Dicks, Angus Dike, Anja Drozd, Ken Edwards, Simon Andrew Forbes, Rebecca Rachael Foster, Kristian A. Gray, Chris Greenman, Kelly Halliday, Katy Hills, Vivienne Kosmidou, Richard Lugg, Andy Menzies, Janet Perry, Robert D. Petty, Keiran M. Raine, Lewis Ratford, Rebecca F. Shepherd, Alexandra C. Small, Yvonne Stephens, Calli Tofts, Jennifer Varian, Sofie West, Sara Widaa, Andrew D. Yates, Francis Brasseur, Colin S. Cooper, Adrienne Margaret Flanagan, Margaret A. Knowles, Suet Yi Leung, David N. Louis, Leendert H. J. Looijenga, Bruce S. Malkowicz, Marco Alessandro Pierotti, Bin Tean Teh, Georgia Chenevix‐Trench, Barbara L. Weber, Siu Tsan Yuen, Grace Harris, Peter Goldstraw, Andrew Gordon Nicholson, P. Andrew Futreal, Richard Wooster, Michael R. Stratton · 发表于：Nature · 年份：2004 · DOI：10.1038/431525b · 被引用次数：800 · 研究领域：Lung Cancer Treatments and Mutations、HER2/EGFR in Cancer Research、PI3K/AKT/mTOR signaling in cancer